3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
36
Neoplasms
17
Breast Neoplasms
14
Carcinoma, Non-Small-Cell Lung
6
Polycystic Ovary Syndrome
4
Lymphoma
4
Lung Neoplasms
4
Sarcopenia
3
Prostatic Neoplasms
3
Fatigue
3
Colorectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Ovarian Neoplasms
2
Obesity
2
Malnutrition
2
Lymphedema
2
Insulin Resistance
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Weight Cycling
1
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Interventions
Nivolumab
28
pembrolizumab
24
cabozantinib
22
Ipilimumab
19
Specimen Handling
14
Magnetic Resonance Spectroscopy
13
Axitinib
12
lenvatinib
10
Radiosurgery
9
belzutifan
8
CTLA-4 Antigen
7
Biopsy
7
atezolizumab
6
cemiplimab
5
Radiotherapy
5
Bevacizumab
5
toripalimab
4
Everolimus
4
Blood Specimen Collection
4
avelumab
3
aldesleukin
3
X-Rays
3
Sunitinib
3
Standard of Care
3
Paclitaxel
3
zimberelimab
2
trastuzumab deruxtecan
2
tivozanib
2
spartalizumab
2
pazopanib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Renal Cell
×
Exercise
×
Clear all
NCT06745609
2025-01-24
Pre-KiT
Herlev and Gentofte Hospital
Phase NA
Recruiting
60 enrolled